NO INDEPENDENT ASSOCIATION BETWEEN A TUMOR-NECROSIS-FACTOR-ALPHA PROMOTOR REGION POLYMORPHISM AND INSULIN-DEPENDENT DIABETES-MELLITUS

被引:85
作者
POCIOT, F [1 ]
WILSON, AG [1 ]
NERUP, J [1 ]
DUFF, GW [1 ]
机构
[1] UNIV SHEFFIELD, ROYAL HALLAMSHIRE HOSP, DEPT MED, MOLEC MED SECT, SHEFFIELD, ENGLAND
关键词
INSULIN-DEPENDENT DIABETES MELLITUS; HLA; TUMOR NECROSIS FACTOR; SUSCEPTIBILITY GENES;
D O I
10.1002/eji.1830231148
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several studies have implicated tumor necrosis factor (TNF)-alpha in the pathogenesis of insulin-dependent diabetes mellitus (IDDM). In the present study we analyzed the first reported TNF-alpha gene polymorphism in relation to IDDM. We have made frequence analysis and tested in vitro lipopolysaccharide (LPS)induced TNF-alpha secretion. A significant difference in allele frequency was observed between patients and controls (p = 0.03). However, a very strong association of the uncommon TNF2 allele was observed with the HLA-B8, -DR3 alleles. The relative risk (RR) of TNF2 was 2.2 compared to a RR of 3.1 for DR3. One reason for this difference was the identification of the TNF1 allele on the otherwise strongly IDDM-associated HLA-DR3 haplotype: DQB1*0201, DQA1*0501, DRB1*:0301, TNFc2, TNFB*2, TNFa1, TNFb5, B18. Thus, the IDDM-associated TNF2 allele had no DR3-independent value as a disease marker. The LPS-induced TNF-alpha production by human monocytes in relation to genotypes demonstrated that TNF1/2 heterozygous individuals had higher, though not statistically significantly (p = 0.08) levels than TNF1-homozygous subjects. However, this difference was rather small, unlikely to be of biological significance and based on the present material we cannot establish the functional importance of this polymorphism.
引用
收藏
页码:3050 / 3053
页数:4
相关论文
共 40 条
[1]   ASSOCIATION BETWEEN HLA-DR2 AND PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 BY MONONUCLEAR-CELLS ACTIVATED BY LIPOPOLYSACCHARIDE [J].
BENDTZEN, K ;
MORLING, N ;
FOMSGAARD, A ;
SVENSON, M ;
JAKOBSEN, B ;
ODUM, N ;
SVEJGAARD, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (05) :599-606
[2]   INTERLEUKIN-1 INDUCED IMPAIRMENT IN PANCREATIC-ISLET OXIDATIVE-METABOLISM OF GLUCOSE IS POTENTIATED BY TUMOR NECROSIS FACTOR [J].
EIZIRIK, DL .
ACTA ENDOCRINOLOGICA, 1988, 119 (03) :321-325
[3]  
FUGGER L, 1989, EUR J HAEMATOL, V43, P254
[4]   GENES ENCODING TUMOR NECROSIS FACTOR-ALPHA AND GRANZYME-A ARE EXPRESSED DURING DEVELOPMENT OF AUTOIMMUNE DIABETES [J].
HELD, W ;
MACDONALD, HR ;
WEISSMAN, IL ;
HESS, MW ;
MUELLER, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2239-2243
[5]   EXPRESSION OF A TUMOR-NECROSIS-FACTOR-ALPHA TRANSGENE IN MURINE PANCREATIC BETA-CELLS RESULTS IN SEVERE AND PERMANENT INSULITIS WITHOUT EVOLUTION TOWARDS DIABETES [J].
HIGUCHI, Y ;
HERRERA, P ;
MUNIESA, P ;
HUARTE, J ;
BELIN, D ;
OHASHI, P ;
AICHELE, P ;
ORCI, L ;
VASSALLI, JD ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1719-1731
[6]   PREVENTION OF DIABETES IN NONOBESE DIABETIC MICE BY TUMOR NECROSIS FACTOR (TNF) - SIMILARITIES BETWEEN TNF-ALPHA AND INTERLEUKIN-1 [J].
JACOB, CO ;
AISO, S ;
MICHIE, SA ;
MCDEVITT, HO ;
ACHAORBEA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :968-972
[7]   HERITABLE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-ASSOCIATED DIFFERENCES IN PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA - RELEVANCE TO GENETIC PREDISPOSITION TO SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
JACOB, CO ;
FRONEK, Z ;
LEWIS, GD ;
KOO, M ;
HANSEN, JA ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :1233-1237
[8]  
JIANG Z, 1991, J IMMUNOL, V146, P2990
[9]   EXTENSIVE GENETIC-POLYMORPHISM IN THE HUMAN TUMOR-NECROSIS-FACTOR REGION AND RELATION TO EXTENDED HLA HAPLOTYPES [J].
JONGENEEL, CV ;
BRIANT, L ;
UDALOVA, IA ;
SEVIN, A ;
NEDOSPASOV, SA ;
CAMBONTHOMSEN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9717-9721
[10]  
LAMPETER EF, 1991, RES CLIN PRACT S1, V14, pS87